Symbiotics
About Symbiotics
Symbiotics is a prominent market access platform specializing in impact investing, focusing on private markets within emerging and frontier economies. The firm offers a comprehensive suite of services, including investment, asset management, and capacity building, aiming to foster sustainable development and financial inclusion. Since its inception in 2005, Symbiotics has originated over 8,200 investments, totaling more than USD 10.5 billion, benefiting 608 companies across 99 countries. The firm's portfolio spans 19 funds and mandates, managing an aggregate of USD 2.5 billion. Additionally, Symbiotics has supported its portfolio companies with over 170 technical assistance projects valued at more than USD 19 million. Symbiotics employs a multifaceted investment strategy targeting various stages of business development, from seed to pre-IPO, and across diverse asset classes such as ESG and impact investing, fixed income, private equity, and venture capital. The firm's geographical focus encompasses a wide range of countries, including Afghanistan, Albania, Algeria, Angola, Argentina, Armenia, Bangladesh, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Burkina Faso, Burundi, Cambodia, Cameroon, Cape Verde, Central African Republic, Chad, China, Colombia, Comoros, Congo (Congo-Brazzaville), Congo (Congo-Kinshasa), Costa Rica, Cote d'Ivoire, Djibouti, Dominican Republic, Ecuador, Egypt, El Salvador, Ethiopia, Fiji, Gabon, Gambia, Ghana, Guatemala, Guinea, Guinea-Bissau, Honduras, India, Indonesia, Jamaica, Jordan, Kenya, Kiribati, Kyrgyzstan, Laos, Lesotho, Liberia, Madagascar, Malawi, Malaysia, Maldives, Mali, Mauritania, Mauritius, Mexico, Micronesia, Moldova, Morocco, Mozambique, Myanmar (Burma), Namibia, Nepal, Nicaragua, Niger, Nigeria, North Macedonia, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Rwanda, Sao Tome and Principe, Senegal, Sierra Leone, Singapore, Solomon Islands, South Africa, South Korea, Sri Lanka, St. Kitts and Nevis, St. Lucia, St. Vincent and the Grenadines, Sudan, Suriname, Swaziland, Syria, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Tuvalu, Uganda, Ukraine, Uruguay, Uzbekistan, Vanuatu, Venezuela, Vietnam, West Bank and Gaza, Yemen, Zambia, and Zimbabwe. The firm's investment philosophy centers on generating measurable social and environmental impact alongside financial returns. Symbiotics has a proven track record in structuring and originating investments that address critical development challenges, such as financial inclusion, renewable energy, and sustainable agriculture. By leveraging its extensive network and expertise, Symbiotics continues to play a pivotal role in mobilizing capital for sustainable development initiatives worldwide.
Investment Mandate
Investment Stages8
Geographical Focus
African markets42
Other stated markets74
Requirements
Focus on emerging and frontier markets, Commitment to sustainable development and financial inclusion, Alignment with UN Sustainable Development Goals (SDGs), Interest in diverse asset classes and investment stages, Willingness to engage in technical assistance and capacity building initiatives
Stated Portfolio5
As reported by the investor. 2 of 5 names match a profile on this platform and links through. The rest are printed as stated.
Is this you?
Claim this investor profile to manage your firm's information.
Claim this profileReport an error